{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T22:34:19Z","timestamp":1778279659281,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Center for Equine Health, University of California, Davis"},{"DOI":"10.13039\/100017060","name":"California Horse Racing Board","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017060","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Meperidine is a synthetic opioid that belongs to the phenylpiperidine class and is a weak mu receptor agonist. In horses there are a limited number of published studies describing the analgesic effects of systemically administered meperidine in horses. The objective of this study was to describe the pharmacokinetics, behavioral and physiologic effects and effect on thermal threshold of three doses of intravenously administered meperidine to horses. Eight University owned horses (four mares and four geldings, aged 3\u20138\u00a0years were studied using a randomized balanced 4-way cross-over design. Horses received a single intravenous dose of saline, 0.25, 0.5 and 1.0\u00a0mg\/kg meperidine. Blood was collected before administration and at various time points until 96 hours post administration. Plasma and urine samples were analyzed for meperidine and normeperidine by liquid chromatography-mass spectrometry and plasma pharmacokinetics determined. Behavioral and physiologic data (continuous heart rate, step counts, packed cell volume, total plasma protein and gastrointestinal sounds) were collected at baseline through 6 hours post administration. The effect of meperidine administration on thermal nociception was determined and thermal excursion calculated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Meperidine was rapidly converted to the metabolite normeperidine. The volume of distribution at steady state and systemic clearance (mean\u2009\u00b1\u2009SD) ranged from 0.829\u2009\u00b1\u20090.138\u20131.58\u2009\u00b1\u20090.280\u00a0L\/kg and 18.0\u2009\u00b1\u20091.4\u201322.8\u2009\u00b1\u20093.60\u00a0mL\/min\/kg, respectively for 0.5\u20131.0\u00a0mg\/kg doses. Adverse effects included increased dose-dependent central nervous excitation, heart rate and cutaneous reactions. Significant effects on thermal nociception were short lived (up to 45 minutes at 0.5\u00a0mg\/kg and 15 minutes at 1.0\u00a0mg\/kg).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Results of the current study do not support routine clinical use of IV meperidine at a dose of 1\u00a0mg\/kg to horses. Administration of 0.5\u00a0mg\/kg may provide short-term analgesia, however, the associated inconsistent and\/or short-term adverse effects suggest that its use as a sole agent at this dose, at best, must be cautiously considered.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12917-020-02564-4","type":"journal-article","created":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T05:09:07Z","timestamp":1601528947000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Meperidine pharmacokinetics and effects on physiologic parameters and thermal threshold following intravenous administration of three doses to horses"],"prefix":"10.1186","volume":"16","author":[{"given":"Briana D.","family":"Hamamoto-Hardman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugene P.","family":"Steffey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel S.","family":"McKemie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip H.","family":"Kass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather K.","family":"Knych","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,1]]},"reference":[{"key":"2564_CR1","doi-asserted-by":"crossref","unstructured":"Bennett RC, Steffey EP. Use of opioids for pain and anesthetic management in horses. Vet Clin North Am Equine Pract. 2002 Apr;18(1):47\u201360.","DOI":"10.1016\/S0749-0739(02)00011-1"},{"key":"2564_CR2","unstructured":"NS M, GL C. Review of Equine Analgesics and Pain Management. AAEP Proc. 2007;53:240\u20134."},{"key":"2564_CR3","doi-asserted-by":"crossref","unstructured":"Baldo BA, Pham NH. Histamine-Releasing and Allergenic Properties of Opioid Analgesic Drugs: Resolving the Two. Anaesth Intensive Care. 2012 Mar;22(2):216\u201335. 40(.","DOI":"10.1177\/0310057X1204000204"},{"key":"2564_CR4","doi-asserted-by":"crossref","unstructured":"Latta KS, Ginsberg B, Barkin RL. Meperidine: A Critical Review. Am J Ther. 2002 Jan;9(1):53\u201368.","DOI":"10.1097\/00045391-200201000-00010"},{"key":"2564_CR5","doi-asserted-by":"crossref","unstructured":"Foreman JH, Ruemmler R. Efficacy of intramuscular meperidine hydrochloride versus placebo in experimental foot lameness in horses. Equine Vet J Suppl. 2013 Dec;45(45):48\u201353.","DOI":"10.1111\/evj.12168"},{"key":"2564_CR6","unstructured":"Muir WW, Robertson JT. Visceral analgesia: effects of xylazine, butorphanol, meperidine, and pentazocine in horses. Am J Vet Res. 1985 Oct;46(10):2081\u20134."},{"key":"2564_CR7","first-page":"43","volume":"21","author":"E Steffey","year":"1994","unstructured":"Steffey E, Pascoe P. Isoflurane and opioid or alpha2-adrenergic drug interaction in horses. J Vet Anaesth. 1994;21:43.","journal-title":"J Vet Anaesth"},{"key":"2564_CR8","unstructured":"DeRossi R, Sampaio BFB, Varela JV, Junqueira AL. Perineal analgesia and hemodynamic effects of the epidural administration of meperidine or hyperbaric bupivacaine in conscious horses. Can Vet J = La Rev Vet Can. 2004 Jan;45(1):42\u20137."},{"key":"2564_CR9","doi-asserted-by":"crossref","unstructured":"Skarda RT, Muir IIIWW. Analgesic, hemodynamic, and respiratory effects induced by caudal epidural administration of meperidine hydrochloride in mares. Am J Vet Res. 2001 Jul;62(7):1001\u20137.","DOI":"10.2460\/ajvr.2001.62.1001"},{"key":"2564_CR10","doi-asserted-by":"crossref","unstructured":"Waterman AE, Amin A. The influence of surgery and anaesthesia on the pharmacokinetics of pethidine in the horse. Equine Vet J Suppl. 1992 Feb;10(11):56\u20138. 24(.","DOI":"10.1111\/j.2042-3306.1992.tb04774.x"},{"issue":"1","key":"2564_CR11","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/S0034-5288(18)33723-8","volume":"17","author":"F Alexander","year":"1974","unstructured":"Alexander F, Collett RA. Pethidine in the horse. Res Vet Sci. 1974;17(1):136\u20137.","journal-title":"Res Vet Sci."},{"issue":"2","key":"2564_CR12","first-page":"108","volume":"7","author":"BE Dahlstr\u00f6m","year":"1979","unstructured":"Dahlstr\u00f6m BE, Paalzow LK, Lindberg C, Bogentoft C. Pharmacokinetics and analgesic effect of pethidine (meperidine) and its metabolites in the rat. Drug Metab Dispos. 1979;7(2): 108-12.","journal-title":"Drug Metab Dispos."},{"issue":"5","key":"2564_CR13","doi-asserted-by":"publisher","first-page":"352","DOI":"10.2165\/00003088-197803050-00002","volume":"3","author":"LE Mather","year":"1978","unstructured":"Mather LE, Meffin PJ. Clinical Pharmacokinetics Pethidine. Clin Pharmacokinet. 1978;3(5):352\u201368.","journal-title":"Clin Pharmacokinet"},{"key":"2564_CR14","doi-asserted-by":"crossref","unstructured":"Morrison JC, Douvas SG, Rhodes PG, Christie RJ, Bucovaz ET, Wiser WL. Meperidine and normeperidine metabolism in the rhesus monkey. Int J Gynaecol Obstet. 1984 Oct;22(5):345\u20138.","DOI":"10.1016\/0020-7292(84)90064-X"},{"issue":"2","key":"2564_CR15","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/j.1875-9114.1994.tb02815.x","volume":"14","author":"LH Danziger","year":"1994","unstructured":"Danziger LH, Martin SJ, Blum RA. Central nervous system toxicity associated with meperidine use in hepatic disease. Pharmacotherapy.\u00a01994; 14(2): 235\u20138.","journal-title":"Pharmacotherapy."},{"key":"2564_CR16","doi-asserted-by":"crossref","unstructured":"Kaiko RF, Foley KM, Grabinski PY, Heidrich G, Rogers AG, Inturrisi CE, et al. Central nervous system excitatory effects of meperidine in cancer patients. Ann Neurol. 1983 Feb;13(2):180\u20135.","DOI":"10.1002\/ana.410130213"},{"issue":"6","key":"2564_CR17","doi-asserted-by":"publisher","first-page":"738","DOI":"10.7326\/0003-4819-86-6-738","volume":"86","author":"HH Szeto","year":"1977","unstructured":"Szeto HH, Inturrisi CE, Houde R, Saal S, Cheigh J, Reidenberg MM. Accumulation of Normeperidine, an Active Metabolite of Meperidine, in Patients with Renal Failure or Cancer.\u00a0Ann Intern Med. 1977; 86(6): 738.","journal-title":"Ann Intern Med."},{"issue":"4","key":"2564_CR18","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/jvp.12759","volume":"42","author":"BD Hamamoto-Hardman","year":"2019","unstructured":"Hamamoto-Hardman BD, Steffey EP, Weiner D, McKemie DS, Kass P, Knych HK. Pharmacokinetics and selected pharmacodynamics of morphine and its active metabolites in horses after intravenous administration of four doses. J Vet Pharmacol Ther. 2019; 42(4):401-410.","journal-title":"J Vet Pharmacol Ther."},{"key":"2564_CR19","doi-asserted-by":"crossref","unstructured":"Reed R, Barletta M, Mitchell K, Hanafi A, Bullington A, Knych H, et al. The pharmacokinetics and pharmacodynamics of intravenous hydromorphone in horses. Vet Anaesth Analg. 2019 May;46(3):395\u2013404.","DOI":"10.1016\/j.vaa.2018.11.001"},{"key":"2564_CR20","doi-asserted-by":"crossref","unstructured":"Callaghan R, Desmond PV, Paull P, Mashford ML. Hepatic enzyme activity is the major factor determining elimination rate of high-clearance drugs in cirrhosis. Hepatology. 1993 Jul;18(1):54\u201360.","DOI":"10.1002\/hep.1840180110"},{"issue":"5","key":"2564_CR21","first-page":"471","volume":"37","author":"FJ Golder","year":"2010","unstructured":"Golder FJ, Wilson J, Larenza P, Fink OT, Ryan MJ. Suspected acute meperidine toxicity in a dog. 2010; 37(5):471-7.","journal-title":"Suspected acute meperidine toxicity in a dog."},{"key":"2564_CR22","doi-asserted-by":"crossref","unstructured":"Moy KV, Ma JD, Best BM, Atayee RS. Factors Impacting Variability of the Urinary Normeperidine-to-Meperidine Metabolic Ratio in Patients with Chronic Pain. J Anal Toxicol. 2014 Jan;38(1)(1):1\u20137.","DOI":"10.1093\/jat\/bkt087"},{"key":"2564_CR23","doi-asserted-by":"crossref","unstructured":"Duthie DJ, Nimmo WS. Adverse effects of opioid analgesic drugs. Br J Anaesth. 1987 Jan;59(1):61\u201377.","DOI":"10.1093\/bja\/59.1.61"},{"issue":"6","key":"2564_CR24","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/j.1365-2885.2007.00911.x","volume":"30","author":"AGP Guedes","year":"2007","unstructured":"Guedes AGP, Papich MG, Rude EP, Rider MA. Comparison of plasma histamine levels after intravenous administration of hydromorphone and morphine in dogs. J Vet Pharmacol Ther. 2007; 30(6):516\u201322.","journal-title":"J Vet Pharmacol Ther."},{"key":"2564_CR25","doi-asserted-by":"crossref","unstructured":"Hermens JM, Ebertz JM, Hanifin JM, Hirshman CA. Comparison of Histamine Release in Human Skin Mast Cells Induced by Morphine, Fentanyl, and Oxymorphone. Anesthesiology. 1985 Feb;62(2):124\u20139.","DOI":"10.1097\/00000542-198502000-00005"},{"key":"2564_CR26","doi-asserted-by":"crossref","unstructured":"Flacke JW, Flacke WE, Bloor BC, Van Etten AP, Kripke BJ. Histamine release by four narcotics: a double-blind study in humans. Anesth Analg. 1987 Aug;66(8):723\u201330.","DOI":"10.1213\/00000539-198708000-00005"},{"issue":"1","key":"2564_CR27","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1746-6148-9-4","volume":"9","author":"C Poller","year":"2013","unstructured":"Poller C, Hopster K, Rohn K, K\u00e4stner SB. Evaluation of contact heat thermal threshold testing for standardized assessment of cutaneous nociception in horses - comparison of different locations and environmental conditions. BMC Vet Res. 2013; 9(1):4.","journal-title":"BMC Vet Res."},{"key":"2564_CR28","doi-asserted-by":"crossref","unstructured":"Poller C, Hopster K, Rohn K, K\u00e4stner SBR. Nociceptive thermal threshold testing in horses - effect of neuroleptic sedation and neuroleptanalgesia at different stimulation sites. BMC Vet Res. 2013 Jul;9:9:135.","DOI":"10.1186\/1746-6148-9-135"},{"issue":"02","key":"2564_CR29","doi-asserted-by":"publisher","first-page":"98","DOI":"10.15653\/TPG-160655","volume":"45","author":"P D\u00f6nselmann Im Sande","year":"2017","unstructured":"Paula D\u00f6nselmann Im Sande, Hopster K, K\u00e4stner S. Einfluss von Morphin, Butorphanol und Levomethadon in unterschiedlicher Dosierung auf den thermischen nozizeptiven Schwellenwert bei Pferden. Tierarztl Prax Ausg G Grosstiere Nutztiere. 2017; 45(02): 98\u2013106.","journal-title":"Tierarztl Prax Ausg G Grosstiere Nutztiere"},{"issue":"Suppl 1","key":"2564_CR30","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1746-6148-10-S1-S6","volume":"10","author":"JR Elfenbein","year":"2014","unstructured":"Elfenbein JR, Robertson SA, MacKay RJ, KuKanich B, Sanchez L. Systemic and anti-nociceptive effects of prolonged lidocaine, ketamine, and butorphanol infusions alone and in combination in healthy horses. BMC Vet Res. 2014;10(Suppl 1):6.","journal-title":"BMC Vet Res"},{"key":"2564_CR31","unstructured":"Muir WW, Skarda RT, Sheehan WC. Cardiopulmonary effects of narcotic agonists and a partial agonist in horses. Am J Vet Res. 1978 Oct;39(10):1632\u20135."},{"key":"2564_CR32","doi-asserted-by":"crossref","unstructured":"S\u00f6bbeler FJ, K\u00e4stner SB. Effects of transdermal lidocaine or lidocaine with prilocaine or tetracaine on mechanical superficial sensation and nociceptive thermal thresholds in horses. Vet Anaesth Analg. 2018 Mar;45(2):227\u201333.","DOI":"10.1016\/j.vaa.2017.10.003"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-020-02564-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12917-020-02564-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-020-02564-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T02:44:00Z","timestamp":1698201840000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-020-02564-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2564"],"URL":"https:\/\/doi.org\/10.1186\/s12917-020-02564-4","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,1]]},"assertion":[{"value":"19 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study has been reviewed and approved by the Institutional Animal Care and\u00a0Use Committee of the University of California, Davis.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Philip Kass is a member of the BMC Veterinary Research Editorial Board (Associate Editor). No other authors have any competing interests or declarations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"368"}}